Abstract:Oxygen free radicals [reactive oxygen species (ROS)] and nitrogen free radicals [reactive nitrogen species (RNS)] are generated by mitochondria during adenosine triphosphate synthesis, and catalytic activities of cytochrome P450, nicotinamide adenine dinucleotide phosphate oxidases (NOXs), cyclooxygenases, and nitric oxide synthases during drug catabolism, phagocytosis, and acute inflammation. Under normal circumstances, low levels of ROS and RNS provide redox signalings that control many essential physiological processes. As age progresses ROS and RNS increase excessively due to dysfunctional mitochondria, dysregulated NOX, and other free-radical generating sources, leading to oxidative stress, which causes oxidation and denaturation of key cellular components including DNA, proteins, and lipids, which become abnormal, constituting damage-associated molecular pattern (DAMP), recognized as ‘non-self’ by immune cells, leading to inflammation which is mediated by nuclear factor kappa B-inflammasome, p38-c-Jun N-terminal kinase and Janus kinase-signal transducer and activator of transcription pathways. DAMPs are continuously released from damaged and senescent cells, causing an otherwise normally transient inflammation turning into systemic chronic inflammation, the root cause of aging and age-associated diseases (AADs). Cells restore redox balance by activating the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway that induces the synthesis and release of antioxidation molecules and enzymes including haem oxygenase-1, which also inhibits the three inflammatory pathways. Furthermore, upregulation of autophagy (AP) can get rid of abnormal molecules, prevent the generation of DAMPs, and attenuate inflammation. Both AP and Nrf2 signalings decrease with age. The upregulations of Nrf2, AP, and downregulation of inflammation are controlled by sensors of energy and stress levels, i.e., adenosine monophosphate-activated protein kinase, silent information regulator 1, and Sestrins, as well as the extracellular matrix, while mammalian targets for rapamycin complex 1, a nutrient sensor, act in the opposite direction. If the balance of these sensor systems becomes dysregulated, aging process accelerates, and the risk of AADs increases.

Oxidative stress and senescence in aging kidneys: the protective role of SIRT1

Cellular Senescence, A Novel Therapeutic Target For Mesenchymal Stem Cells In Acute Kidney Injury

Abstract 186: Impaired Nucleocytoplasmic Shuttling and Activity of SIRT1 in Response to Ischemic Stress in the Senescent Heart

Sirtuin 3 in renal diseases and aging: From mechanisms to potential therapies

Redox signaling in aging kidney and opportunity for therapeutic intervention through natural products

Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease

The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence

Aging, oxidative stress and degenerative diseases: mechanisms, complications and emerging therapeutic strategies

The influential responsibility of sirtuins in senescence and associated diseases: A review

Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury

Oxidative stress and inflammation: the root causes of aging

The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis

Renal Fibrosis: SIRT1 Still of Value

Oxidative Stress-Induced Cellular Senescence in Aging Retina and Age-Related Macular Degeneration

Redox Regulation of SIRT1 in Inflammation and Cellular Senescence.

Sirtuin 1: A Target for Kidney Diseases

Sirt3 Attenuates Oxidative Stress Damage and Rescues Cellular Senescence in Rat Bone Marrow Mesenchymal Stem Cells by Targeting Superoxide Dismutase 2

Sirtuins in kidney health and disease

Cellular senescence and kidney aging

The role of SIRT1 in kidney diseases

Aging, ROS, and cellular senescence: a trilogy in the progression of liver fibrosis